false
0001494891
0001494891
2025-11-10
2025-11-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
____________________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): November 10, 2025
SENSUS
HEALTHCARE, INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
001-37714 |
|
27-1647271 |
| (State of Incorporation) |
|
(Commission File
Number) |
|
(IRS Employer Identification
No.) |
| |
|
|
|
|
851
Broken Sound Pkwy., NW # 215, Boca Raton, Florida |
|
33487 |
| (Address
of principal executive offices) |
|
(Zip Code) |
Registrant's
telephone number, including area code: (561) 922-5808
_________________________________________________
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
| |
☐ |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
|
| |
☐ |
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
|
| |
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
|
| |
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which
registered |
| Common Stock, par
value $0.01 per share |
|
SRTS |
|
Nasdaq Stock Market,
LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
SENSUS
HEALTHCARE, INC.
FORM
8-K
CURRENT
REPORT
ITEM
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers
(d)
On
November 10, 2025, the Board of Directors (the “Board”) of Sensus Healthcare, Inc. (the “Company”) appointed
Eric Sachetta as a Class II director of the Company for a term expiring at the Company’s annual meeting in 2026. Mr.
Sachetta fills a vacancy resulting from the death of William McCall.
Mr.
Sachetta, age 37, is Chief Wealth Services Officer of Sachetta, LLC, a financial advisory firm founded by Mr. Sachetta. In that
role, his responsibilities include leading and managing the firm’s financial advisory division and overseeing all wealth
management operations and advisor development. Before assuming his current position in 2022, he held other positions with the
firm from 2016. Mr. Sachetta’s previous employment included serving as a leadership speaker and author and as a district
manager of a marketing organization. He is a Certified Financial Planner® and holds other licenses and certifications. Mr.
Sachetta received a bachelor’s degree in Corporate Finance and Accounting from Bentley University.
There
are no arrangements or understandings between Mr. Sachetta and any other persons pursuant to which he was elected, nor does
he have any direct or indirect material interest in any transaction required to be disclosed under Item 404(a) of Securities
and Exchange Commission Regulation S-K. As a director of the Company, Mr. Sachetta is expected to receive the same compensation
for service as a director as is provided to other non-employee directors of the Company on a pro-rata annual
basis. The Board has determined that Mr. Sachetta is an independent director within the meaning of Rule 5605(a)(2) as
set forth in the listing standards of The NASDAQ Stock Market, LLC. Mr. Sachetta has been appointed as a member
of the Audit Committee of the Board.
On
November 12, 2025, the Company issued a press release announcing Mr. Sachetta’s election. The press release is filed as
an exhibit to this Report. The press release shall not be deemed "filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except
as shall be expressly set forth by specific reference in such filing.
| Item 9.01 |
Financial Statements and Exhibits |
(d)
Exhibits
| 99.1 | Press
Release dated November 12, 2025. |
| 104 | Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
| |
SENSUS HEALTHCARE, INC. |
| |
|
| Date: November
13, 2025 |
By: |
/s/ Javier Rampolla |
|
| |
|
Javier Rampolla |
| |
|
Chief Financial Officer |
EXHIBIT
INDEX
| |
|
Exhibit
Number |
Description |
| 99.1 |
Press Release, dated November 12, 2025 |
| 104 |
Cover Page Interactive
Data File (embedded within the Inline XBRL document) |
